Company / Free Cash Flow per Share
Charles River Laboratories Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$10.53
FY2025
5-year range
$6.84 / $10.53
FY2021-FY2025
Trend
+7.8%
vs FY2024
Sector context
#20 of 149
Health Care
What the data says
Charles River Laboratories's free cash flow per share of $10.53 is higher than 87% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $4.89 in FY2019 to $10.53 in FY2025.
Based on SEC 10-K filings.
10.53 in FY2025 with a 5-year CAGR of +11.4%. Top quartile in the Health Care sector.
Remained stable around $10.53 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +11.9%
- 5-Year CAGR
- +11.4%
- 10-Year CAGR
- -
Sector benchmark
+110.6% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 7.8% year-over-year.
- Ranks #20 out of 149 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.53 | +7.8% |
| FY2024 | $9.77 | -6.4% |
| FY2023 | $10.44 | +38.7% |
| FY2022 | $7.53 | +10.1% |
| FY2021 | $6.84 | +11.2% |
| FY2020 | $6.15 | +25.9% |
| FY2019 | $4.89 | -23.0% |
| FY2018 | $6.35 | +27.7% |
| FY2017 | $4.98 | -11.2% |
| FY2016 | $5.60 | +56.1% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026